About the Dermatitis Herpetiformis Session
Dermatitis herpetiformis (DH) is a chronic, autoimmune skin condition characterized by intense itching and blistering, often resembling herpes but unrelated to the virus. It is closely linked to celiac disease and gluten sensitivity, as the body’s immune response to gluten can trigger the skin manifestations. Typically, DH presents as small, itchy bumps or blisters, commonly found on the elbows, knees, and buttocks.
Diagnosis involves a skin biopsy and blood tests for specific antibodies. Treatment primarily includes a strict gluten-free diet, which helps reduce symptoms and prevent flare-ups. Additionally, medications like dapsone may be prescribed to alleviate itching and inflammation. Understanding DH is essential for dermatologists and cosmetologists, as they may encounter patients with skin concerns stemming from this underlying condition, highlighting the importance of a holistic approach in treatment and skincare regimens.
Featured Speakers — Dermatitis Herpetiformis 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Dermatitis Herpetiformis Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Dermatitis Herpetiformis Conference 2027
Present Your Research
Oral and poster slots for original Dermatitis Herpetiformis work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Dermatitis Herpetiformis research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Dermatitis Herpetiformis track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Dermatitis Herpetiformis Conference 2027 — FAQs
What is the Dermatitis Herpetiformis track at IDC 2027?
The Dermatitis Herpetiformis track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Dermatitis Herpetiformis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Dermatitis Herpetiformis sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Dermatitis Herpetiformis are all welcome — whether presenting or attending.
Can I present my research in the Dermatitis Herpetiformis track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Dermatitis Herpetiformis sessions?
Yes. IDC 2027 is a hybrid conference — attend the Dermatitis Herpetiformis track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.